/Stay Informed – Updates on DCC-2618

Stay Informed – Updates on DCC-2618

By |2018-10-29T13:57:44+00:00November 17th, 2017|Clinical Trials, Webcast|

LRG Webcast Series

On Monday, November 13th, The Life Raft Group in collaboration with Deciphera Pharmaceuticals hosted a webcast which provided patients with an overview of the DCC-2618 GIST program, including enrollment updates from the ongoing phase 1 trial, reviewed key clinical data and provided details on the upcoming Phase 3 registration trial for the treatment of patients who have received at least 3 prior therapies. The webcast closed with a Q&A session.

Oliver Rosen, MD, Chief Medical Officer and Jama Pitman, VP Regulatory Affairs and Quality, both of Deciphera Pharmaceuticals, presented.


Oliver Rosen, MD

Oliver Rosen, MD
Chief Medical Officer
Deciphera Pharmaceuticals

Jama Pitman

Jama Pitman
VP Regulatory Affairs & Quality
Deciphera Pharmaceuticals

Play Webcast

Recent Posts

Upcoming Events

  1. GDOL Los Angeles 2019

    February 16, 2019 @ 8:00 AM - 5:00 PM